drugset / Trial / NCT02246868
An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.
Treatment
Summary
The main objectives of this study are to compare the first and second recovery assessments and recovery when a subject changed batch and to assess whether haemostasis was achieved with Optivate® when treating a bleed. The secondary objectives are to evaluate the clinical tolerance and safety of Optivate®.
Timeline
- Start
- 2001-09
- Primary completion
- 2004-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Coagulation Factor VIII | Protein / enzyme biologic | — | — |